Governance Zoetis Inc.

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-01-12 pm EST			5-day change	1st Jan Change
125.32 ^USD	-1.45%		-0.48%	-0.40%

05:26pm	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
02:50pm	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM

Executive Committee: Zoetis Inc.

Manager

Positions heldSince

Kristin Peck

54 year

Chief Executive Officer

2019-12-31

Julie Fuller

53 year

Chief Operating Officer	2024-07-31
Human Resources Officer	2024-07-31

Richard Goldstein

Chief Tech/Sci/R&D Officer

2024-03-20

Keith Sarbaugh

48 year

Chief Tech/Sci/R&D Officer

2023-02-28

Wetteny Joseph

54 year

Director of Finance/CFO

2021-05-31

Roxanne Lagano

61 year

General Counsel	2024-04-15
Corporate Secretary	2024-04-15

Steven Frank

Investor Relations Contact

2015-02-28

Composition of the Board of Directors: Zoetis Inc.

Director

CommitteesSince

Michael McCallister

73 year

Audit Committee	2011-10-31
HR Committee	2013-01-31

Frank D'Amelio

68 year

Governance Committee
Nominating Committee
Audit Committee Chair	2003-08-31
Audit Committee	2023-01-09
HR Committee Chair
Finance Committee	2025-05-04

Gregory Norden

68 year

HR Committee
Audit Committee Chair	2019-02-28
Governance Committee	2020-07-29
Nominating Committee	2020-07-29
Compensation Committee	2019-02-28

Antoinette Leatherberry

64 year

Audit Committee	2022-01-31
HR Committee
Compensation Committee	2022-01-31
Governance Committee Chair	2022-01-31
Nominating Committee Chair	2022-01-31

Sanjay Khosla

73 year

HR Committee
Governance Committee	2021-08-31
Nominating Committee	2021-08-31
Compensation Committee Chair	2021-08-31

Paul Bisaro

65 year

HR Committee	2015-04-30
Governance Committee	2022-10-30
Nominating Committee	2022-10-30

Stephanie Schear-Tilenius

59 year

Audit Committee	2013-12-31
Finance Committee	2013-12-31

Louise Parent

75 year

Audit Committee	2013-07-31
Governance Committee Chair

Kristin Peck

54 year

Governance Committee	2024-09-30
Nominating Committee	2024-09-30

Willie Reed

71 year

Governance Committee

2014-03-03

Gavin Hattersley

63 year

Governance Committee

2024-03-31

Vanessa Broadhurst

57 year

Governance Committee

Mark Stetter

Director/Board Member	2025-05-20
Independent Dir/Board Member	2025-05-20

Latest Appointments: Zoetis Inc.

Nov. 03	Zoetis announces retirement of Rob Polzer at the end of 2025 and the appointment of Kevin Esch as president of research & development for world leader in animal health beginning in 2026	RE
Nov. 03	Zoetis Inc. Announces Executive Changes	CI
25-10-28	Zoetis Inc. Appoints Stephanie Tilenius to Its Board of Directors, Effective December 1, 2025	CI
25-10-28	Zoetis appoints Stephanie Tilenius to its board of directors	RE
25-05-22	Zoetis Inc. Announces Board Changes Effective May 21, 2025	CI
25-05-22	Zoetis Inc. Approves the Election of Dr. Mark Stetter to Its Board of Directors, Effective from May 21, 2025	CI
25-03-20	Roche Announces Management Changes	CI

More news

Former Officers and Directors: Zoetis Inc.

Insider

Positions held

SinceUntil

Robert Polzer

Chief Tech/Sci/R&D Officer	2021-12-31	2025-12-30
Corporate Officer/Principal	2014-12-31	2021-12-31

Robert Scully

Director/Board Member	2013-05-31	2025-05-20
Independent Dir/Board Member	2013-05-31	2025-05-20

Wafaa Mamilli

Chief Tech/Sci/R&D Officer

2019-12-31

2024-11-10

Ester Banque

Corporate Officer/Principal

2023-07-09

2024-11-10

Mike McFarland

Chief Tech/Sci/R&D Officer

2020-10-31

2024-07-31

Linda Rhodes

Director/Board Member	2017-08-03	2024-05-20
Independent Dir/Board Member	2017-08-03	2024-05-20

Heidi Chen

General Counsel	2012-09-30	2024-04-15
Corporate Secretary	2012-09-30	2024-04-15

Glenn David

Director of Finance/CFO	2016-08-17	2021-05-31
Corporate Officer/Principal	2021-05-31	2023-02-04

Roman Trawicki

Corporate Officer/Principal

2022-07-30

Catherine Knupp

Chief Tech/Sci/R&D Officer

2012-09-30

2021-12-30

Sherry Pudloski

Public Communications Contact

2020-02-29

2021-11-30

John O'Connor

Investor Relations Contact	-	-
Public Communications Contact	-	-
Corporate Officer/Principal	-	-
Treasurer	-	2021-11-30

William Steere

Director/Board Member	2012-12-31	2021-05-19
Independent Dir/Board Member	2014-01-06	2021-05-19

Katherine Walden

Compliance Officer

2012-10-31

2021-04-30

Pablo Lamberto

Corporate Officer/Principal

2017-12-31

2020-12-31

Andrew Fenton

Chief Tech/Sci/R&D Officer

2013-12-31

2020-05-31

Timothy Bettington

Corporate Officer/Principal

2019-12-31

Juan Alaix

Director/Board Member	2012-06-30	2019-12-30
Chief Executive Officer	2012-06-30	2019-12-30

Clinton Lewis

Corporate Officer/Principal

2012-12-31

2019-12-30

Dong Kim

Comptroller/Controller/Auditor

2017-12-31

2019-06-30

Alejandro Bernal

Corporate Officer/Principal

2012-09-30

2018-02-27

Colleen Cunningham

Comptroller/Controller/Auditor

2011-12-31

2017-12-31

Paul Herendeen

Director of Finance/CFO

2014-09-01

2016-08-17

Stefan Weiskopf

Corporate Officer/Principal

2012-09-30

2016-04-30

Bill Doyle

Director/Board Member	2015-02-02	2016-02-29
Independent Dir/Board Member	2015-02-02	2016-02-29

William Ackman

Director/Board Member

2015-02-03

Gloria Basse

Corporate Officer/Principal

1984-12-31

2014-12-31

Joyce Lee

Corporate Officer/Principal

2012-09-30

2014-12-31

Richard A. Passov

Director of Finance/CFO

2012-06-30

2014-04-21

Ky Nam-Wortman

Corporate Officer/Principal

2011-12-31

2013-12-31

Inez Blankestijn

Human Resources Officer

2009-12-31

2013-12-31

Amy Schulman

Director/Board Member

2012-06-30

2013-06-23

Douglas Giordano

Director/Board Member

2012-06-30

2013-06-23

Charles H. Hill

Director/Board Member

2012-06-30

2013-06-23

Geno Germano

Director/Board Member

2012-06-30

2013-06-23

Scott Webster

Corporate Officer/Principal

2012-03-26

Jim Bradford

Corporate Officer/Principal

2012-03-26

Sandra J. Beaty

Investor Relations Contact	-	-
Corporate Officer/Principal	2011-12-31	-

Ronald Green

Chief Operating Officer

2007-12-31

2009-12-31

Paul Wood

Corporate Officer/Principal

2003-12-31

Gerard G. Gorman

Chief Tech/Sci/R&D Officer	2000-12-31	2000-12-31
Director of Finance/CFO	2000-12-31	2000-12-31

James Fraser MacKenzie

Sales & Marketing

2000-12-31

Nat Ricciardi

Corporate Officer/Principal

1994-12-31

1998-12-31

Rick Ryan

Corporate Officer/Principal

1995-12-31

1998-12-30

Carl-Johan Ehn

Corporate Officer/Principal

Kyung Nam-Wortman

Corporate Officer/Principal

J. McFarland

Chief Tech/Sci/R&D Officer

Susanne P. Reilly

Human Resources Officer

Nigel Hebart

Corporate Officer/Principal

Bill Price

Public Communications Contact

Riff Yeager

Corporate Officer/Principal

Elizabeth Williams

Corporate Officer/Principal

Michelle Tollefson

Corporate Officer/Principal

2011-04-18

Ian Read

President

Olivier Nazeyrollas

Corporate Officer/Principal

Thomas Darling

General Counsel	2010-06-08	-
Corporate Officer/Principal	-	2010-06-08

George Gunn

President

Roger Schein

Corporate Officer/Principal

Laura Pires

Corporate Officer/Principal

2011-04-18

Steve Sornsen

Corporate Officer/Principal

Gerard P. Davis

Director/Board Member

George Fennell

Corporate Officer/Principal	-	-
Sales & Marketing	2003-03-31	2010-12-31

Elinore Y. White

Public Communications Contact

David Alan Brake

Corporate Officer/Principal

Jim Myers

Corporate Officer/Principal

Allen Moczygemba

Sales & Marketing

John T. Gray

Corporate Officer/Principal

Michael van Blommestein

Corporate Officer/Principal

Colin Giles

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	16
Female	8

Of which Executive Committee

Male	5
Female	2

Of which Directors

Male	8
Female	5

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.

Employees

13,800

Sector

Pharmaceuticals

Calendar

01:30pm - J.P. Morgan Healthcare Conference

More about the company